Andrew S. Delemos
Expertise in
16
conditions

Dr. Andrew S. Delemos

Gastroenterology | Hepatology | Internal Medicine
1025 Morehead Medical Drive, Suite 600, 
Charlotte, NC 
On Staff At
Accepting New Patients
Offers Telehealth
Expertise in
16
conditions
1025 Morehead Medical Drive, Suite 600, 
Charlotte, NC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Andrew Delemos is an Internal Medicine specialist and a Hepatologist in Charlotte, North Carolina. Dr. Delemos is highly rated in 16 conditions, according to our data. His top areas of expertise are Cirrhosis, Nonalcoholic Steatohepatitis (NASH), Hepatitis, Visceromegaly, and Liver Transplant. Dr. Delemos is currently accepting new patients.

His clinical research consists of co-authoring 30 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
University Of Pennsylvania
Residency
Massachusetts General Hospital
Specialties
Gastroenterology
Hepatology
Internal Medicine
Licenses
Internal Medicine in NC
Board Certifications
American Board Of Internal Medicine, Gastroenterology
American Board Of Internal Medicine
American Board Of Internal Medicine, Transplant Hepatology
Fellowships
Massachusetts General Hospital
Hospital Affiliations
Atrium Health Union
Atrium Health Lincoln
Atrium Health Cleveland
Carolinas Medical Center/behav Health
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Absolute Total Care South Carolina
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
Aetna
  • EPO
  • HMO
  • POS
  • PPO
AmeriHealth
  • EPO
  • HMO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Sentara Healthcare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

Transplant and Liver Center
1025 Morehead Medical Drive, Suite 600, Charlotte, NC 28204

Additional Areas of Focus

Dr. Delemos has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)
Autoimmune Hepatitis
Liver Transplant

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
A Phase 2, Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Magnesium in Patients With Primary Biliary Cholangitis (EPICS )
A Phase 2, Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Magnesium in Patients With Primary Biliary Cholangitis (EPICS )
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug
Study Phase: Phase 2
2017-01: Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma
2017-01: Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma
Enrollment Status: Completed
Publish Date: August 06, 2020
Intervention Type: Other
A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults With Nonalcoholic Steatohepatitis (NASH)
A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults With Nonalcoholic Steatohepatitis (NASH)
Enrollment Status: Terminated
Publish Date: November 25, 2019
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Emricasan, an Oral Caspase Inhibitor, in Subjects With Decompensated Non-Alcoholic Steatohepatitis (NASH) Cirrhosis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Emricasan, an Oral Caspase Inhibitor, in Subjects With Decompensated Non-Alcoholic Steatohepatitis (NASH) Cirrhosis
Enrollment Status: Unknown
Publish Date: March 19, 2019
Intervention Type: Drug
Study Drug: Emricasan
Study Phase: Phase 2
View 4 Less Clinical Trials

30 Total Publications

Donor-Recipient Race Mismatch Is Associated with Lower Survival After Liver Transplantation for Primary Sclerosing Cholangitis.
Donor-Recipient Race Mismatch Is Associated with Lower Survival After Liver Transplantation for Primary Sclerosing Cholangitis.
Journal: Journal of clinical medicine
Published: June 23, 2025
Similar Doctors
Mark W. Russo
Expertise in
19
conditions
Dr. Mark W. Russo
Gastroenterology | Hepatology
Expertise in
19
conditions
Dr. Mark W. Russo
Gastroenterology | Hepatology

Transplant And Liver Center

1025 Morehead Medical Drive, Suite 600, 
Charlotte, NC 
 (0.7 miles away)
704-355-6649
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Mark Russo is a Hepatologist and a Gastroenterologist in Charlotte, North Carolina. Dr. Russo is highly rated in 19 conditions, according to our data. His top areas of expertise are Hepatitis, Visceromegaly, Cirrhosis, Liver Transplant, and Hepato-Pancreato-Biliary Surgery. Dr. Russo is currently accepting new patients.

Expertise in
73
conditions
Dr. Tarun K. Narang
Gastroenterology
Expertise in
73
conditions
Dr. Tarun K. Narang
Gastroenterology

Carolina Digestive Health Associates PA

10620 Park Rd, Suite 102, 
Charlotte, NC 
 (7.4 miles away)
704-543-7305
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Tarun Narang is a Gastroenterologist in Charlotte, North Carolina. Dr. Narang is highly rated in 73 conditions, according to our data. His top areas of expertise are Erythema Nodosum, Bile Duct Obstruction, Cholestasis, Endoscopy, and Gastrectomy. Dr. Narang is currently accepting new patients.

Fred C. Fowler
Expertise in
58
conditions
Dr. Fred C. Fowler
Gastroenterology | Hepatology
Expertise in
58
conditions
Dr. Fred C. Fowler
Gastroenterology | Hepatology

Carolina Digestive Health Associates PA

1085 Ne Gateway Ct Ne, Suite 280, 
Concord, NC 
 (22.6 miles away)
704-455-9700
Experience:
39+ years
Languages Spoken:
English, German
See accepted insurances
Accepting New Patients
Offers Telehealth

Fred Fowler is a Hepatologist and a Gastroenterologist in Concord, North Carolina. Dr. Fowler has been practicing medicine for over 39 years is highly rated in 58 conditions, according to our data. His top areas of expertise are Lower Esophageal Ring, Benign Esophageal Stricture, Swallowing Difficulty, Gastrectomy, and Endoscopy. Dr. Fowler is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Delemos's expertise for a condition
ConditionClose
    View All 8 Distinguished Conditions
    View All 8 Advanced Conditions
    View All 15 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile